Efficacy, Safety, and Systemic Exposure of Once-Daily Indacaterol Acetate in Pediatric Asthma: A Randomized, Double-Blind, Controlled Dose-Finding Study

BACKGROUND: Indacaterol acetate (IND), a long-acting β(2)-agonist in combination with mometasone furoate (MF), an inhaled corticosteroid (ICS), is being explored as a once-daily (od) treatment for asthma in children. This study examined the efficacy, safety, and systemic exposure of IND 75 µg and IN...

Descripción completa

Detalles Bibliográficos
Autores principales: Sekerel, Bulent Enis, Nell, Haylene, Laki, Istvan, Pak, Tatiana, Contreras, Edgar, Kolarz, Adam, D’Andrea, Peter, Manga, Volkan, Jain, Monish, Vaidya, Soniya, Valentin, Michele, Sen, Biswajit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514176/
https://www.ncbi.nlm.nih.gov/pubmed/37682405
http://dx.doi.org/10.1007/s40261-023-01300-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514176/
https://www.ncbi.nlm.nih.gov/pubmed/37682405
http://dx.doi.org/10.1007/s40261-023-01300-8

Ejemplares similares